Clough Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,580
| Closed | -$252K | – | 127 |
|
|
2024
Q3 | $252K | Hold |
3,580
| – | – | 0.03% | 128 |
|
|
2024
Q2 | $295K | Hold |
3,580
| – | – | 0.03% | 114 |
|
|
2024
Q1 | $313K | Hold |
3,580
| – | – | 0.03% | 115 |
|
|
2023
Q4 | $345K | Hold |
3,580
| – | – | 0.04% | 165 |
|
|
2023
Q3 | $317K | Sell |
3,580
-44,390
| -93% | -$3.93M | 0.03% | 155 |
|
|
2023
Q2 | $4.16M | Buy |
+47,970
| New | +$4.16M | 0.42% | 72 |
|
|
2019
Q3 | – | Sell |
-70,689
| Closed | -$6.06M | – | 100 |
|
|
2019
Q2 | $6.06M | Sell |
70,689
-700
| -1% | -$60K | 0.59% | 61 |
|
|
2019
Q1 | $6.34M | Buy |
71,389
+10,000
| +16% | +$888K | 0.55% | 63 |
|
|
2018
Q4 | $5.23M | Buy |
61,389
+25,444
| +71% | +$2.17M | 0.61% | 59 |
|
|
2018
Q3 | $3.49M | Sell |
35,945
-4,500
| -11% | -$436K | 0.33% | 68 |
|
|
2018
Q2 | $3.81M | Buy |
40,445
+4,100
| +11% | +$386K | 0.34% | 71 |
|
|
2018
Q1 | $2.95M | Sell |
36,345
-3,100
| -8% | -$251K | 0.28% | 76 |
|
|
2017
Q4 | $3.52M | Sell |
39,445
-9,200
| -19% | -$820K | 0.29% | 70 |
|
|
2017
Q3 | $4.53M | Sell |
48,645
-1,500
| -3% | -$140K | 0.3% | 75 |
|
|
2017
Q2 | $4.55M | Sell |
50,145
-53,364
| -52% | -$4.85M | 0.32% | 72 |
|
|
2017
Q1 | $9.09M | Buy |
103,509
+5,800
| +6% | +$509K | 0.58% | 54 |
|
|
2016
Q4 | $8.09M | Buy |
97,709
+33,509
| +52% | +$2.78M | 0.54% | 58 |
|
|
2016
Q3 | $5.94M | Buy |
64,200
+60,400
| +1,589% | +$5.59M | 0.31% | 90 |
|
|
2016
Q2 | $296K | Buy |
+3,800
| New | +$296K | 0.02% | 170 |
|